DGHMC
KIN

Dalton, Greiner, Hartman, Maher & Co’s Kindred Biosciences, Inc. KIN Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio KIN Stock Details KIN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
2019
Q3 		$971K Buy